The aim of this study was to determine the relationship between physical fitness, cardiopulmonary function and patient-reported severity of symptoms in people with post-COVID-19 condition. We examined ambulatory patients (n = 72) with post-COVID-19 condition who had a chronic symptomatic phase lasting > 12 weeks from the onset of symptoms, but had not been hospitalized for acute COVID-19. A comprehensive medical screening was conducted, including clinical history, symptomatology, comorbidities, body composition and physical activity levels. We then identified the relationship between physical fitness (cardiorespiratory fitness and muscular strength), cardiopulmonary function (echocardiographic and spirometry parameters) and patient-reported severity of symptoms (fatigue, dyspnea, health-related quality of life, anxiety, and depression). Age, body mass index, sex, number of comorbidities and duration of symptoms were included as potential confounders. Results showed that greater physical fitness and cardiopulmonary function were associated with lower severity of symptoms in people with post-COVID-19 condition. Cardiorespiratory fitness, lower-limb muscle strength, maximal voluntary ventilation and left ventricular ejection fraction account for reducing fatigue and dyspnea. Greater physical activity levels were associated with fewer symptoms and less-severe fatigue and dyspnea. In conclusion, preserving better cardiopulmonary health and physical condition during the course of the disease-even in mild cases-was related to a lower intensity of symptoms in non-hospitalized people with post-COVID-19 condition. It is probable that exercise and physical conditioning are valuable pre- and post-COVID-19 countermeasures that could help decrease the severity, not only of acute infection, but of post-COVID-19 persistent symptoms and prognosis.

Department of Infectious Diseases Hospital Universitario Santa Lucía 30202 Cartagena Murcia Spain

Department of Physiology and Biochemistry Faculty of Physical Education and Sport Charles University 16252 Prague Czech Republic

Family Medicine Residency Hospital Universitario Virgen de La Arrixaca 30120 Murcia Spain

Human Performance and Sports Science Laboratory Faculty of Sport Sciences University of Murcia 30730 San Javier Murcia Spain

Erratum v

Intern Emerg Med. 2022 Nov;17(8):2453. doi: 10.1007/s11739-022-03089-4. PubMed

Zobrazit více v PubMed

WHO Headquarters (HQ) (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus PubMed PMC

Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417. PubMed DOI PMC

Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health related quality of life (HRQoL)—A systematic review and meta-analysis. J Med Virol. 2021 doi: 10.1002/jmv.27309. PubMed DOI PMC

Delbressine JM, Machado FVC, Goërtz YMJ, et al. The impact of post-covid-19 syndrome on self-reported physical activity. Int J Environ Res Public Health. 2021 doi: 10.3390/ijerph18116017. PubMed DOI PMC

Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (long COVID): a scoping review. Front Med. 2021 doi: 10.3389/fmed.2021.750378. PubMed DOI PMC

Zhang X, Wang F, Shen Y, et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open. 2021;4:1–11. doi: 10.1001/jamanetworkopen.2021.27403. PubMed DOI PMC

Søraas A, Kalleberg KT, Dahl JA, et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS ONE. 2021;16:1–13. doi: 10.1371/journal.pone.0256142. PubMed DOI PMC

Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546–2553. doi: 10.1111/jth.15490. PubMed DOI PMC

Yan Z, Yang M, Lai CL. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. 2021 doi: 10.3390/BIOMEDICINES9080966. PubMed DOI PMC

Utrero-Rico A, Ruiz-Ruigómez M, Laguna-Goya R, et al. (2021) A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomedicines. 2021;9:1540. doi: 10.3390/BIOMEDICINES9111540. PubMed DOI PMC

Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, et al. Post-covid-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. 2021;18:5329. doi: 10.3390/ijerph18105329. PubMed DOI PMC

Severinsen MCK, Pedersen BK. Muscle-organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41:594–609. doi: 10.1210/endrev/bnaa016. PubMed DOI PMC

Nieman DC. Exercise is medicine for immune function: implication for COVID-19. Curr Sports Med Rep. 2021;20:395–401. doi: 10.1249/JSR.0000000000000867. PubMed DOI

Hallam J, Jones T, Alley J, Kohut ML. Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects. Brain Behav Immun. 2022;102:1–10. doi: 10.1016/j.bbi.2022.02.005. PubMed DOI PMC

Sallis R, Young DR, Tartof SY, et al. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients. Br J Sports Med. 2021 doi: 10.1136/bjsports-2021-104080. PubMed DOI

Brawner CA, Ehrman JK, Bole S, et al. Inverse relationship of maximal exercise capacity to hospitalization secondary to coronavirus disease 2019. Mayo Clin Proc. 2021;96:32–39. doi: 10.1016/j.mayocp.2020.10.003. PubMed DOI PMC

Cassar MP, Tunnicliffe EM, Petousi N, et al. Symptom persistence despite improvement in cardiopulmonary health–insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. 2021 doi: 10.1016/j.eclinm.2021.101159. PubMed DOI PMC

Lam GY, Befus AD, Damant RW, et al. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir Res. 2021 doi: 10.1186/s12931-021-01814-9. PubMed DOI PMC

Baratto C, Caravita S, Faini A, et al. Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130:1470–1478. doi: 10.1152/japplphysiol.00710.2020. PubMed DOI PMC

Borghesi A, Maroldi R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Medica. 2020;125:509–513. doi: 10.1007/S11547-020-01200-3/FIGURES/3. PubMed DOI PMC

Rodríguez Ledo P, Armenteros del Olmo L, Rodríguez Rodríguez E, Gómez AF. Descripción de los 201 síntomas de la afectación multiorgánica producida en los pacientes afectados por la COVID-19 persistente. Med Gen Y Fam. 2021;10:60–68. doi: 10.24038/MGYF.2021.016. DOI

Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Heal. 2009;6:790–804. doi: 10.1123/jpah.6.6.790. PubMed DOI

Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451–1462. doi: 10.1136/bjsports-2020-102955. PubMed DOI PMC

Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J Clin Epidemiol. 1998;51:1171–1178. doi: 10.1016/S0895-4356(98)00109-7. PubMed DOI

Monteagudo Piqueras O, Hernando Arizaleta L, Palomar Rodríguez JA. Normas poblacionales de referencia de la versión española del SF-12V2 para la Región de Murcia. Gac Sanit. 2011;25:50–61. doi: 10.1016/j.gaceta.2010.09.001. PubMed DOI

Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166:1092–1097. doi: 10.1001/archinte.166.10.1092. PubMed DOI

Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. PubMed DOI PMC

Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–586. doi: 10.1378/chest.93.3.580. PubMed DOI

Jackson C. The Chalder Fatigue Scale (CFQ 11) Occup Med (Chic Ill) 2015;65:86. doi: 10.1093/occmed/kqu168. PubMed DOI

Krupp LB, Larocca NG, Muir Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–1123. doi: 10.1001/archneur.1989.00520460115022. PubMed DOI

Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res. 2010;69:17–22. doi: 10.1016/J.JPSYCHORES.2009.10.007. PubMed DOI

Sunnquist M, Lazarus S, Jason LA. The development of a short form of the DePaul symptom questionnaire. Rehabil Psychol. 2019 doi: 10.1037/REP0000285. PubMed DOI PMC

Klok FA, Boon GJAM, Barco S, et al. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020 doi: 10.1183/13993003.01494-2020. PubMed DOI PMC

Ekblom-Bak E, Björkman F, Hellenius ML, Ekblom B. A new submaximal cycle ergometer test for prediction of VO2max. Scand J Med Sci Sport. 2014;24:319–326. doi: 10.1111/sms.12014. PubMed DOI

Ekblom-Bak E (2020) Reference values for VO2max. Accessed July 15 2021. https://www.gih.se/Global/3_forskning/fysiologi/elinekblombak/Reference%20values%20EB-test_20201201_eng.pdf

Buendía-Romero Á, Hernández-Belmonte A, Martínez-Cava A, et al. Isometric knee extension test: a practical, repeatable, and suitable tool for lower-limb screening among institutionalized older adults. Exp Gerontol. 2021 doi: 10.1016/j.exger.2021.111575. PubMed DOI

Courel-Ibáñez J, Martínez-Cava A, Morán-Navarro R, et al. Reproducibility and repeatability of five different technologies for bar velocity measurement in resistance training. Ann Biomed Eng. 2019;47:1523–1538. doi: 10.1007/s10439-019-02265-6. PubMed DOI

Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr. 2019;32:1–64. doi: 10.1016/j.echo.2018.06.004. PubMed DOI

Graham BL, Steenbruggen I, Barjaktarevic IZ, et al. Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200:E70–E88. doi: 10.1164/rccm.201908-1590ST. PubMed DOI PMC

Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK Statistical bulletins-Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/previousReleases?page=1. Accessed 10 May 2022

Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Heal - Eur. 2021;6:1–8. doi: 10.1016/j.lanepe.2021.100122. PubMed DOI PMC

Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70. doi: 10.1016/j.ejim.2021.06.009. PubMed DOI PMC

Vanichkachorn G, Newcomb R, Cowl CT, et al. Post–COVID-19 Syndrome (long haul syndrome): description of a multidisciplinary clinic at mayo clinic and characteristics of the initial patient cohort. Mayo Clin Proc. 2021;96:1782–1791. doi: 10.1016/j.mayocp.2021.04.024. PubMed DOI PMC

Vaes AW, Goërtz YMJ, Van HM, et al. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021;7:00141–02021. doi: 10.1183/23120541.00141-2021. PubMed DOI PMC

Wilke J, Mohr L, Tenforde AS, et al. A pandemic within the pandemic? Physical activity levels substantially decreased in countries affected by covid-19. Int J Environ Res Pub Health. 2021;18:1–12. doi: 10.3390/ijerph18052235. PubMed DOI PMC

Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention-Full Text View-ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04718506. Accessed 12 May 2022

Vonbank K, Lehmann A, Bernitzky D, et al. Predictors of prolonged cardiopulmonary exercise impairment after covid-19 infection: a prospective observational study. Front Med. 2021;8:1–9. doi: 10.3389/fmed.2021.773788. PubMed DOI PMC

Pleguezuelos E, Del Carmen A, Llorensi G, et al. Severe loss of mechanical efficiency in COVID-19 patients. J Cachexia Sarcopenia Muscle. 2021;12:1056–1063. doi: 10.1002/jcsm.12739. PubMed DOI PMC

Singh I, Joseph P, Heerdt PM, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2021 doi: 10.1016/j.chest.2021.08.010. PubMed DOI PMC

Crameri GAG, Bielecki M, Züst R, et al. Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020. Eurosurveillance. 2020;25:1. doi: 10.2807/1560-7917.ES.2020.25.36.2001542. PubMed DOI PMC

Szekely Y, Lichter Y, Sadon S, et al. Cardiorespiratory abnormalities in patients recovering from coronavirus disease 2019. J Am Soc Echocardiogr. 2021 doi: 10.1016/j.echo.2021.08.022. PubMed DOI PMC

Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, et al. Chronotropic incompetence in non-hospitalized patients with post-covid-19 syndrome. J Clin Med. 2021;10:1–10. doi: 10.3390/jcm10225434. PubMed DOI PMC

Ismael F, Bizario JCS, Battagin T, et al. Post-infection depressive, anxiety and post-traumatic stress symptoms: a prospective cohort study in patients with mild COVID-19. Prog Neuropsychopharmacol Biol Psychiatry. 2021 doi: 10.1016/J.PNPBP.2021.110341. PubMed DOI PMC

Post-COVID Syndrome and Cardiorespiratory Fitness-26-Month Experience of Single Center